版本:
中国

BRIEF-CSL Behring says Australian Therapeutic Goods Administration approved Afstyla

April 19 CSL Behring

* Csl behring -australian therapeutic goods administration approved afstyla a recombinant single chain coagulation factor viii in patients with haemophilia a Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐